GlassScriptPhysician profile
Ravi K Prakash
NPI 1053575399
$8,835.78
in general payments reported to CMS, 2019-2025
21 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $782 · 2020: $814 · 2021: $527 · 2022: $824 · 2023: $3,520 · 2024: $1,341 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,850 · Food and Beverage: $1,766 · Travel and Lodging: $1,673 · Honoraria: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,850.00 |
| Food and Beverage | $1,766.40 |
| Travel and Lodging | $1,672.91 |
| Honoraria | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $2,088.68 | 2019-2024 | Esophyx |
| Boston Scientific Corporation | $1,831.07 | 2021-2025 | Spyglass, Exalt Model D, General - Biliary Devices |
| Mauna Kea Technologies, INC. | $1,637.22 | 2019-2025 | |
| Olympus Corporation of The Americas | $863.37 | 2023 | Disposable Distal Attachment, Olympus, Single Use Electrosurgical Hemostatic Forceps |
| US Endoscopy | $850.00 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $303.52 | 2019-2022 | |
| Medtronic, INC. | $205.85 | 2023-2024 | Prodigi, Endoflip |
| Abbvie INC. | $180.48 | 2021-2024 | |
| Apollo Endosurgery US INC | $153.21 | 2022-2023 | Overstitch Endoscopic Suturing System |
| Takeda Pharmaceuticals U.S.A., INC. | $145.96 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $122.92 | 2024 | Alphaone |
| Covidien LP | $121.15 | 2020 | |
| Ambu INC. | $108.85 | 2021 | |
| Janssen Biotech, INC. | $61.69 | 2023-2024 | Stelara |
| Braintree Laboratories, INC. | $39.22 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $37.17 | 2022 | |
| Phathom Pharmaceuticals, INC. | $22.62 | 2024 | Voquezna |
| Gilead Sciences, INC. | $20.92 | 2019 | |
| Pfizer INC. | $16.18 | 2024 | |
| Enterra Medical, INC. | $14.34 | 2022 | |
| Allergan, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Prakash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.